[Present and future of oral pertussis vaccination].
Parenteral immunization against whooping cough shows some disadvantages which led to proposals to curtail pertussis vaccination in some countries. As a result a striking rise in pertussis morbidity in these regions was noted, so vaccination against whooping cough is still indicated. We developed an oral vaccine for the neonate to achieve a protective immunity at a time when it is especially needed and to avoid side-reactions. Oral vaccine was given to more than 15,000 newborns, vaccination results of the last 3 years are reported.
D000284:Administration, Oral; D003362:Cost-Benefit Analysis; D004673:Encephalomyelitis, Acute Disseminated / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D010567:Pertussis Vaccine / Q000008:administration & dosage*; D011946:Receptors, Antigen; D014611:Vaccination / Q000639:trends; D014917:Whooping Cough / Q000517:prevention & control*
D010567:Pertussis Vaccine; D011946:Receptors, Antigen
Gegenwart und Zukunft der oralen Pertussis-Schutzimpfung.